Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Aspiration Thrombectomy
Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for Vessels of the Peripheral Arterial and Venous Systems
04/22/2024

Expanse Medical Press Release

Expanse Medical Press Release
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the...
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the...
PLEASANTON, Calif., April 22,...
04/22/2024
Vascular Disease Management
COVID-19
COVID-19 Increases Risk of Severe Cardiovascular Problems in People With HIV
04/19/2024

Germans Trias i Pujol Research Institute News

Germans Trias i Pujol Research Instit...
People living with HIV who have experienced an episode of COVID-19 face a significant increase in the risk of cardiovascular diseases in the year following infection. According to a study conducted with the PISCIS cohort, individuals with HIV...
People living with HIV who have experienced an episode of COVID-19 face a significant increase in the risk of cardiovascular diseases in the year following infection. According to a study conducted with the PISCIS cohort, individuals with HIV...
People living with HIV who have...
04/19/2024
Cath Lab Digest

Advertisement

REsearch
JAMA: Industry Gifts May Influence Which Cardiac Device is Used in Common Lifesaving Procedure
04/18/2024

University of Pittsburgh News

University of Pittsburgh News
Using the national disclosure program Open Payments, the authors examined marketing-related payments from the LVAD manufacturer to cardiologists from 2016 to 2018, then linked these data to Medicare claims to determine which devices were...
Using the national disclosure program Open Payments, the authors examined marketing-related payments from the LVAD manufacturer to cardiologists from 2016 to 2018, then linked these data to Medicare claims to determine which devices were...
Using the national disclosure...
04/18/2024
Cath Lab Digest
Nanoparticle Therapies
Smart Nanoparticles May Be Able to Deliver Drugs to Heart After Heart Attack
04/18/2024

Washington University in St. Louis News

Washington University in St. Louis Ne...
With a four-year, $2.07 million grant from the NIH, researchers plan to enclose a set of proteins designed to curb inflammation and a peptide to prevent fibrosis inside cleverly disguised drug-delivering smart nanoparticles. These...
With a four-year, $2.07 million grant from the NIH, researchers plan to enclose a set of proteins designed to curb inflammation and a peptide to prevent fibrosis inside cleverly disguised drug-delivering smart nanoparticles. These...
With a four-year, $2.07 million...
04/18/2024
Cath Lab Digest
TAVR
Caranx Medical Announces Successful Robotic-Assisted Transcatheter Heart Valve Implantation in an Animal
04/17/2024

Caranx Medical News

Caranx Medical News
“The team at Caranx has achieved an important milestone as it successfully deployed a balloon-expandable device in the aortic position, in a pig model. This extremely promising step paves the way to a first-in-human utilization," says Dr....
“The team at Caranx has achieved an important milestone as it successfully deployed a balloon-expandable device in the aortic position, in a pig model. This extremely promising step paves the way to a first-in-human utilization," says Dr....
“The team at Caranx has achieved...
04/17/2024
Cath Lab Digest

Advertisement

Intravascular Lithotripsy
FastWave Medical Extends Intellectual Property Portfolio With the Issuance of Its Utility Patent for Novel Laser-IVL Technology
04/16/2024

FastWave Medical Inc. News

FastWave Medical Inc. News
"FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy," says Dr. William Nicholson. "It also enables FastWave's team of engineers to develop an ultra-sleek balloon...
"FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy," says Dr. William Nicholson. "It also enables FastWave's team of engineers to develop an ultra-sleek balloon...
"FastWave's novel approach has...
04/16/2024
Cath Lab Digest
PerQseal Elite Vascular Closure System
Venous Closure
Vivasure Medical Announces First Large Hole Venous Patient Treated With PerQseal Elite Vascular Closure System
04/15/2024

Vivasure Medical News

Vivasure Medical News
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully...
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully...
Vivasure Medical, a company...
04/15/2024
Cath Lab Digest
Wrist-based monitoring
Researchers Demonstrate the Potential for Verily's Study Watch to Help Identify Patients at Risk for Heart Failure
04/11/2024

Verily News

Verily News
A study conducted by Verily, Duke University, and Stanford University demonstrates that the walking behavior captured by Verily Study Watch, a wrist-worn device designed for research purposes, is associated with different levels of heart...
A study conducted by Verily, Duke University, and Stanford University demonstrates that the walking behavior captured by Verily Study Watch, a wrist-worn device designed for research purposes, is associated with different levels of heart...
A study conducted by Verily,...
04/11/2024
Cath Lab Digest

Advertisement

Tricuspid Valve Treatment
First Patient Enrolled in VISTA U.S. Study Evaluating Novel Tricuspid Valve Replacement Technology
04/11/2024

Minneapolis Heart Institute Foundation® News

Minneapolis Heart Institute Foundatio...
Minneapolis Heart Institute Foundation® (MHIF) announced the first enrollment in the VISTA U.S. early feasibility study offering a new transcatheter tricuspid valve technology for severe tricuspid valve regurgitation. Paul Sorajja, MD,...
Minneapolis Heart Institute Foundation® (MHIF) announced the first enrollment in the VISTA U.S. early feasibility study offering a new transcatheter tricuspid valve technology for severe tricuspid valve regurgitation. Paul Sorajja, MD,...
Minneapolis Heart Institute...
04/11/2024
Cath Lab Digest
Lower-extremity intervention
Revascularization Enhances Quality of Life for Patients With Chronic Limb-Threatening Ischemia
04/10/2024

Brigham and Women's Hospital / Boston Medical Center News

Brigham and Women's Hospital / Boston...
“Our study indicates that patients with CLTI have a notably poor quality of life – substantially lower than with many other chronic conditions,” said Matthew Menard, MD. “Our findings show that revascularization significantly improves quality...
“Our study indicates that patients with CLTI have a notably poor quality of life – substantially lower than with many other chronic conditions,” said Matthew Menard, MD. “Our findings show that revascularization significantly improves quality...
“Our study indicates that...
04/10/2024
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use